Session Details
[28-14-pm]Physical Chemistry and Biophysics 3
Sat. Mar 28, 2026 3:30 PM - 5:30 PM JST
Sat. Mar 28, 2026 6:30 AM - 8:30 AM UTC
Sat. Mar 28, 2026 6:30 AM - 8:30 AM UTC
Room 14 (C507, Bldg. 2, Area 2 [5F])
Chair: Satoru Nagatoishi, Hiromichi Nakahara
[28-14-pm09]Structural characterization of mouse NKT T-cell receptor
○Shunsuke Kita1, Ryu Miyauchi1, Minori Akita1, HIroki Kusaka1, Takashi Tadokoro2, Shigeru Sugiyama3, Toshihiko Aiba4, Koichi Fukase4, Michio Murata4, Masato Sumi1, Shinsuke Inuki5, Yukari Fujimoto6, Katsumi Maenaka1 (1. Facul. Pharm. Sci., Hokkaido Univ, 2. Facul. Pharm. Sci., Sanyo-Onoda City Univ, 3. Grad. Sch. Sci., Kochi Univ, 4. Facul. Sci., Osaka Univ, 5. Facul. Pharm. Sci., Kyoto Univ, 6. Facul. Sci., Keio Univ)
[28-14-pm10]Enhanced cellular uptake of extracellular vesicles using a curvature-sensing peptide
○Kenichi Kawano1,2, Kenta Hosokawa1, Yuuto Oosugi1, Aoi Taniguchi1, Akinori Soga3, Jun Kawamoto3, Yuki Kuzuma1, Katsumi Matsuzaki1, Kenichi Nagase2 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 3. Inst. Chem. Res., Kyoto Univ.)
[28-14-pm11]Enhancement of cytokine secretion in cellular tissues through the orientation of mesenchymal stem cells
○Kenichi Nagase1, Hasumi Kuramochi2, David W Grainger3, Hironobu Takahashi4 (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Grad. Pharm. Sci., Keio Univ., 3. Dept. Biomed. Eng., Univ of Utah, 4. Inst Adv. Biomed. Eng. Sci., Tokyo Women's Med. Univ.)
[28-14-pm12]Electrochemical CYP3A4 Catalysis as a Tool for Medium-Sized Molecule Conversion
○Yasuhiro Mie1, Chitose Mikami1, Teruhiro Nakao2, Chikara Oie2, Hirofumi Tsujino2,3 (1. AIST, 2. Sch. Pharm. Sci., UOsaka, 3. Museum Links, UOsaka)
[28-14-pm13]Dual Binding Modes of Nateglinide with Human Serum Albumin
○Akito Kawai1, Koji Nishi2,3, Masahiro Tokuno2, Masaki Otagiri2,3, Keishi Yamasaki2,3 (1. Fujita Health Univ. Sch. of Med., 2. Sojo Univ. Dep. of Pharm., 3. Sojo Univ. DDS Res. Inst.)
[28-14-pm14]In Vitro–In Vivo Correlation between Disintegration and Absorption Profiles of Generic Drugs in the Fed Bioequivalence Study
○Masaki Higashino1, Hideo Takeda2, Akane Shirahama2, Ryo Tanabe2 (1. Towa Pharmaceutical Co., Ltd., 2. Physio Mckina Co., Ltd.)
[28-14-pm15]Analysis of the Effects of Ion Hydration Shells on Compound Behavior
○Koji Ogata1 (1. Sanyo-Onoda City University)
[28-14-pm16]Development of halogen-substituted photosensitizers for photoimmunotherapy with improved photochemical efficiency
○Yuto Goto1, Osamu Inanami1, Mikako Ogawa1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[28-14-pm17]Synthesis of rare-earth fluoride nanocrystals by thermal decomposition of complexes and their potential optical and magnetic applications
○Akira Kawashima1, Takuya Miyawaki1, Takuya Ishida2, Tetsu Tatsuma3, Shigeru Kohtani1 (1. Sch.Pharm., Hyogo Medical Univ., 2. CORE, Utsunomiya Univ., 3. IIS, the Univ. of Tokyo)
[28-14-pm18]Bisphosphonate Functionalized Gadolinium Oxide Nanoparticles as Non-Ionizing Contrast Agents to Detect Bone Turnover
○Michael Doschak1, Adibehalsadat Ghazanfari1, David J. Perez2, Antonio Vega-Medina1, Carlos A. Velázquez-Martinez1, Richard B. Thompson3, Jacob L. Jaremko4, Neal M. Davies1 (1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada, 2. Tecnologico Nacional de Mexico, Campus Colima, 3. Faculty of Medicine & Dentistry, Department of Biomedical Engineering, University of Alberta, 4. Faculty of Medicine & Dentistry, Department of Radiology & Diagnostic Imaging, University of Alberta)
